Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avita Medical Ltd (RCEL)
:RCEL
RCEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.51 - $18.93
Previous CloseN/A
Volume824.49K
Average Volume (3M)248.68K
Market Cap
$262.26M
Enterprise Value$279.77M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.49
Next Earnings
May 08, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.39
Shares Outstanding26,357,542
10 Day Avg. Volume261,988
30 Day Avg. Volume248,678
Standard Deviation0.20
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.49
Price to Cash Flow (P/CF)-9.30
P/FCF Ratio0.00
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.71
Enterprise Value/Ebitda-5.21
Forecast
1Y Price Target
$16.20Price Target Upside62.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Avita Medical News
PremiumCompany Announcements
AVITA Medical Reports Transformative Year Amidst Challenges
PremiumCompany Announcements
AVITA Medical Reports Revenue Growth Amid New Product Approvals
---
Bulls Say, Bears Say
Bulls Say
Portfolio ExpansionAvita is building out its portfolio to cover the broad spectrum of wound care, opening the door to massive TAM-expanding opportunities.
Revenue GrowthAvita's flagship RECELL platform is generating nice traction, as evidenced by the 29% revenue growth performance.
Bears Say
Revenue GuidanceRCEL reaffirmed FY25 guidance of $100M-$106M, which is considered too aggressive and may require a significant ramp in existing product growth.
---
Ownership Overview
1.16% Insiders
8.52% Mutual Funds
1.56% Other Institutional Investors
79.30% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCEL FAQ
What was Avita Medical Ltd’s price range in the past 12 months?
Avita Medical Ltd lowest stock price was $7.51 and its highest was $18.93 in the past 12 months.
What is Avita Medical Ltd’s market cap?
Avita Medical Ltd’s market cap is $262.26M.
When is Avita Medical Ltd’s upcoming earnings report date?
Avita Medical Ltd’s upcoming earnings report date is May 08, 2025 which is in 76 days.
How were Avita Medical Ltd’s earnings last quarter?
Avita Medical Ltd released its earnings results on Feb 13, 2025. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.429 by -$0.011.
Is Avita Medical Ltd overvalued?
According to Wall Street analysts Avita Medical Ltd’s price is currently Undervalued.
Does Avita Medical Ltd pay dividends?
Avita Medical Ltd does not currently pay dividends.
What is Avita Medical Ltd’s EPS estimate?
Avita Medical Ltd’s EPS estimate is -0.32.
How many shares outstanding does Avita Medical Ltd have?
Avita Medical Ltd has 26,357,542 shares outstanding.
What happened to Avita Medical Ltd’s price movement after its last earnings report?
Avita Medical Ltd reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.429. Following the earnings report the stock price went up 20.387%.
Which hedge fund is a major shareholder of Avita Medical Ltd?
Among the largest hedge funds holding Avita Medical Ltd’s share is Hussman Strategic Advisors Inc. It holds Avita Medical Ltd’s shares valued at 0.
---
Avita Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.20 (62.81% Upside)
$16.20 (62.81% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 42.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $139.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.40%
12-Months-Change
Fundamentals
Return on Equity
-230.96%
Trailing 12-Months
Asset Growth
-28.60%
Trailing 12-Months
Company Description
Avita Medical Ltd
Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
---
RCEL Company Deck
---
RCEL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
AVITA Medical's earnings call reflected a transformative year with substantial revenue growth, improved gross profit margins, and a significant increase in total addressable market due to new product launches. However, the company faced challenges with a Q4 revenue shortfall, increased net losses, and higher operating expenses, which balanced the positive achievements.Read More>---
RCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
---
RCEL Stock 12 Month Forecast
Average Price Target
$16.20
▲(62.81% Upside)
Technical Analysis
Best Analysts Covering RCEL
1 Year
1 Year Success Rate
4/13 ratings generated profit
1 Year Average Return
-15.76%
reiterated a buy rating 5 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -15.76% per trade.
---